Skip to main content
Cell Bio Human Tech Co., Ltd logo

Cell Bio Human Tech Co., Ltd — Investor Relations & Filings

Ticker · 318160 ISIN · KR7318160009 KO Professional, scientific and technical activities
Open in API
Filings indexed 146 across all filing types
Latest filing 2026-05-20 Director's Dealing
Country KR South Korea
Listing KO 318160

About Cell Bio Human Tech Co., Ltd

http://cellbiohumantech.co.kr/en/

Cell Bio Human Tech Co., Ltd. is a company that develops and manufactures advanced nonwoven fabrics for the cosmetics sector. Utilizing cellulose reaction technology, the company produces specialized materials primarily for sheet masks and skincare pads. Its products, derived from various cellulose fibers, are engineered for differentiated performance, offering features such as high transparency and adhesion. The company provides customizable and eco-friendly fabric solutions, with key product lines including PT Cell and S Cell.

Recent filings

Filing Released Lang Actions
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 85% confidence The document is a Korean ‘임원ㆍ주요주주 특정증권등 소유상황보고서’ which details an executive’s share ownership and purchase transactions (dates, quantities, pre-/post-transaction balances). This matches a director’s or insider’s personal share transaction report. Therefore, it is a Director’s Dealing report.
2026-05-20 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 99% confidence The document is a statutory disclosure of an officer’s and major shareholder’s holdings and changes in holdings of company securities, detailing dates, share counts, and transaction types. This matches the insider transaction reporting requirement (director’s dealing).
2026-05-20 Korean
[기재정정]유형자산취득결정(자율공시)
Regulatory Filings Classification · 80% confidence The document is a voluntary regulatory disclosure (“자율공시”) concerning the company’s decision to acquire tangible fixed assets (land and building) and an amendment to the payment date. It details the asset, price, board resolution, and other investment-related information. There are no financial statements, no share or debt issuance, no M&A takeover or financing activity, and no earnings or dividend information. This is a standalone regulatory announcement that does not fit into any specialized financial report category. Therefore, it should be classified as a general Regulatory Filing (RNS).
2026-05-15 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is titled “분기보고서” covering the period 2026-01-01 to 2026-03-31 (제12기 1분기), contains detailed company overview, business content, products, and financial tables. It is a full quarterly financial report for a period shorter than a fiscal year, with substantive data and analysis. This matches the definition of an Interim/Quarterly Report (Code: IR). Q1 2026
2026-05-14 Korean
감자완료
Regulatory Filings
2026-05-07 Korean
주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares Classification · 90% confidence The document is a Korean "주요사항보고서" disclosing the board’s decision to enter into a trust contract for acquiring treasury (own) shares. It details contract terms, share quantities, and legal limits for self-share acquisition. This is a direct report of the company’s own-share transaction (treasury stock acquisition), matching the “Transaction in Own Shares” category. It is not simply an announcement of an attached report, nor a fundraising, dividend, or board change notice.
2026-04-14 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.